DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread

Conditions:   Adenocarcinoma Gastric Stage IV With Metastases;   Adenocarcinoma - GEJ Intervention:   Drug: Trastuzumab deruxtecan Sponsor:   Daiichi Sankyo, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials